Prestigious Award Honors Pioneering Body's Defenses Research
This year's prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the immune system targets dangerous infections while sparing the healthy tissues.
Three renowned scientists—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.
Their work uncovered specialized "sentinels" within the defense system that remove rogue immune cells that could harming the body.
The findings are now paving the way for innovative therapies for immune disorders and cancer.
These winners will divide a prize fund valued at 11m SEK.
Decisive Findings
"The research has been essential for comprehending how the body's defenses functions and why we do not all develop severe autoimmune diseases," stated the head of the Nobel Committee.
This team's studies explain a fundamental question: How does the immune system defend us from numerous infections while leaving our own tissues unharmed?
The body's protection system employs white blood cells that search for indicators of disease, including pathogens and germs it has not met before.
Such defenders employ detectors—known as recognition units—that are produced by chance in countless combinations.
This gives the defense network the ability to fight a broad range of invaders, but the unpredictability of the process unavoidably creates immune cells that may target the host.
Security Guards of the Immune System
Scientists previously knew that a portion of these problematic white blood cells were eliminated in the thymus—where white blood cells mature.
The latest award recognizes the identification of T-reg cells—known as the body's "peacekeepers"—which patrol the body to disarm any defenders that attack the body's own tissues.
We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.
A prize committee added, "The discoveries have established a new field of investigation and accelerated the development of new therapies, for instance for tumors and immune disorders."
In malignancies, regulatory T-cells block the system from attacking the growth, so research are aimed at reducing their numbers.
In self-attack disorders, trials are exploring increasing T-reg cells so the body is not being harmed. A similar method could also be effective in reducing the risks of transplanted organ rejection.
Pioneering Experiments
Prof Sakaguchi, of Osaka University, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.
The researcher showed that injecting defense cells from other mice could stop the illness—implying there was a system for blocking defenders from harming the host.
Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a gene vital for how T-regs operate.
"The pioneering work has revealed how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," said a prominent biological science expert.
"This research is a remarkable example of how basic biological research can have far-reaching implications for human health."
